Clinical Trials Directory

Trials / Completed

CompletedNCT00818194

Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers

A Comparison of Effects of Short-term Low Dose Exposure of Advagraf® and Neoral® Microemulsion Cyclosporine A on Renal Perfusion and Function in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Astellas Pharma Inc · Industry
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the effects of steady state tacrolimus vs. cyclosporine on renal pharmacodynamics in healthy volunteers.

Detailed description

This study seeks to evaluate the renal physiological responses of short-term maintenance level doses of CNIs in healthy volunteers to determine if daily perturbations in renal physiology exist, and if confirmed, whether they differ between CNIs and thus may contribute by different mechanisms to the progression of CAN.

Conditions

Interventions

TypeNameDescription
DRUGextended release tacrolimusoral
DRUGcyclosporine A microemulsionoral

Timeline

Start date
2008-04-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2009-01-07
Last updated
2014-07-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00818194. Inclusion in this directory is not an endorsement.

Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volun (NCT00818194) · Clinical Trials Directory